COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment

David Salisbury   ¹ , FMedScI ;   Jeffrey V Lazarus   ^{2, 3} , MIH, MA, PhD ;   Nancy Waite   ⁴ , PharmD ;   Clara Lehmann   ⁵ , MD ;   Sumitra Sri Bhashyam   ⁶ , MSc, PhD ;   Marie de la Cruz   ⁷ , MS ;   Beth Hahn   ⁸ , PhD ;   Matthew D Rousculp   ⁸ , PhD ;   Paolo Bonanni   ⁹ , MD

¹ Programme for Global Health, Royal Institute of International Affairs, Chatham House, London, United Kingdom

² Graduate School of Public Health and Health Policy (CUNY SPH), City University of New York, New York, NY, United States

³ Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain

⁴ School of Pharmacy, University of Waterloo, Ontario, ON, Canada

⁵ Department of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany

⁶ ICON Insights, Evidence and Value—Patient Centered Outcomes, Reading, United Kingdom

⁷ ICON Insights, Evidence and Value—Patient Centered Outcomes, Raleigh, NC, United States

⁸ Novavax, Inc, Gaithersburg, MD, United States

⁹ Department of Health Services, University of Florence, Florence, Italy